BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11672578)

  • 21. Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment.
    Nowak-Göttl U; Kenet G; Mitchell LG
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):103-14. PubMed ID: 19285277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V; Thomas KB; Sauter S; Niemeyer CM; Sutor AH
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk factors for thrombosis in children with acute lymphoblastic leukemia.
    Sivaslioglu S; Gursel T; Kocak U; Kaya Z
    Clin Appl Thromb Hemost; 2014 Sep; 20(6):651-3. PubMed ID: 23364161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.
    Kosch A; Junker R; Kurnik K; Schobess R; Günther G; Koch H; Nowak-Göttl U
    Thromb Res; 2000 Sep; 99(6):531-7. PubMed ID: 10974337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
    Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
    Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Escherichia coli asparaginase antibody levels determine the activity of second-line treatment with pegylated E coli asparaginase: a retrospective analysis within the ALL-BFM trials.
    Willer A; Gerss J; König T; Franke D; Kühnel HJ; Henze G; von Stackelberg A; Möricke A; Schrappe M; Boos J; Lanvers-Kaminsky C
    Blood; 2011 Nov; 118(22):5774-82. PubMed ID: 21940824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombosis and acute leukemia.
    Crespo-Solís E
    Hematology; 2012 Apr; 17 Suppl 1():S169-73. PubMed ID: 22507812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.
    Heller C; Schobess R; Kurnik K; Junker R; Günther G; Kreuz W; Nowak-Göttl U
    Br J Haematol; 2000 Nov; 111(2):534-9. PubMed ID: 11122096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol.
    Sutor AH; Mall V; Thomas KB
    Klin Padiatr; 1999; 211(4):201-4. PubMed ID: 10472550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asparagine concentration in plasma after 2,500 IU/m(2) PEG-asparaginase i.v. in children with acute lymphoblastic leukemia.
    Wenner KA; Vieira Pinheiro JP; Escherich G; Wessalowski R; Jorch N; Wolff J; Stehn M; Kohlschütter A; Boos J; Janka-Schaub GE
    Klin Padiatr; 2005; 217(6):321-6. PubMed ID: 16307417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
    Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
    Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low rate of severe venous thromboses in children with ALL treatment according to COALL-92 and -97 protocol.
    Mauz-Körholz C; Nürnberger W; Irsfeld H; Körholz D; Göbel U
    Klin Padiatr; 1999; 211(4):215-7. PubMed ID: 10472553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
    Lee JH; Lee J; Yhim HY; Oh D; Bang SM
    J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet aggregation is stimulated by L-asparginase in children with acute lymphoblastic leukemia and normal individuals.
    Jaime-Perez JC; Gomez-Almaguer D
    Haematologica; 2002 Aug; 87(8):891-2. PubMed ID: 12161371
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children.
    Nowak-Göttl U; Kuhn N; Wolff JE; Boos J; Kehrel B; Rath B; Jürgens H
    Eur J Haematol; 1996; 56(1-2):35-8. PubMed ID: 8599991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombosis and acute lymphoblastic leukaemia.
    Payne JH; Vora AJ
    Br J Haematol; 2007 Aug; 138(4):430-45. PubMed ID: 17608766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.
    Giordano P; Molinari AC; Del Vecchio GC; Saracco P; Russo G; Altomare M; Perutelli P; Crescenzio N; Santoro N; Marchetti M; De Mattia D; Falanga A
    Am J Hematol; 2010 May; 85(5):325-30. PubMed ID: 20425794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors for Central Nervous System thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre cohort study.
    Duarte X; Esteves S; Neto AM; Pereira F
    Br J Haematol; 2016 Jul; 174(2):280-91. PubMed ID: 27018199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.